Latest Truvada news
Texas Judge Says ACA Cannot Require Coverage for PrEP
posted September 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
HIV Pre-Exposure Prophylaxis Linked to Drop in Condom Use
posted June 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
For gay and bisexual men, an increase in HIV pre-exposure prophylaxis is associated with a reduction in condom use, according to a study published online June 6 in The Lancet HIV.
FDA Approves Generic Version of HIV Drug Truvada
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
The first generic version of the HIV drug Truvada (emtricitabine and tenofovir disoproxil fumarate) has been approved by the U.S. Food and Drug Administration.
Patient Infected With HIV Despite Long-Term Adherence to PrEP
posted February 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
In a letter to the editor published in the Feb. 2 issue of the New England Journal of Medicine, authors report on a patient who has become infected with HIV despite long-term adherence to pre-exposure prophylaxis.
FDA Could Ease Blood Donation Rules for Gay Men 
Another Significant HIV Vaccine Trial Fails 
Women Experiencing Intimate Partner Violence More Likely to Contract HIV 
Cognitive Behavioral Intervention Ups ART Adherence in Adolescents, Young Adults 
PrEP for Men at High Risk for HIV May Be Taken on Demand 
CDC: PrEP Rx Needs to Increase for Optimal HIV Prevention Monthly Specialist Briefings
Stay Connected
